Ixekizumab-induced cutaneous vasculitis: A rare challenge in the era of biologic therapies
Eine Yesid Benavides Tulcán, Sara Isabel Vanegas Arciniegas, Edgar Andrés Lozano Ponce · 2026
Read Ixekizumab-induced cutaneous vasculitis: A rare challenge in the era of biologic therapies by Eine Yesid Benavides Tulcán, Sara Isabel Vanegas Arciniegas, Edgar Andrés Lozano Ponce (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13396620.txt.
Description
Eine Yesid Benavides Tulcán and others tell of ixekizumab-linked skin vessel flare in a 2026 case tale. IL-17 block drugs treat skin scale and joint scale illness well, with known risks like yeast sores and gut flare, but vessel flare stays rare and dim.
A 74-year-old woman with high blood pressure and a smoke past had plaque and harsh joint scale illness. She broke out in vessel flare on ixekizumab, one of few such tales on IL-17 block drugs. Swift naming of this defense-linked flare shapes timely care and drug swaps. Prescribers gain a rare drug harm to watch for.
Catalog record
| CREATOR | Eine Yesid Benavides Tulcán, Sara Isabel Vanegas Arciniegas, Edgar Andrés Lozano Ponce |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 11 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |